Cited by 5Advanced Drug Delivery SystemsOvarian function and disordersNanoparticle-Based Drug Delivery

Linum usitatissimum Delivery over Chitosan Nanobiopolymer: Enhanced Effects on Polycystic Ovary Syndrome Condition

Open access
Bayrami, Abolfazl, Sojoudi, Maryam, Rahim Pouran, Shima, Habibi-Yangjeh, Aziz, Sojoudi, Sanaz·2024·IET Nanobiotechnology

Abstract

L.) extract (FSE). The number of main features and bio-interface properties of CHIT-FSE were determined by SEM, DLS, FTIR, XRD, TGA, and zeta potential analyses and compared to those of chitosan lacking FSE. A GC-MS analysis was also conducted to reveal the bioactive compounds of FSE. The active anchoring of the FSE phytomolecules over chitosan nanoparticles with enhanced thermal and structural stability was correspondingly verified. Subsequently, the influence of CHIT-FSE, CHIT-TPP, and FSE supplementation was assessed on hormonal and biochemical markers of polycystic ovary syndrome (PCOS) in female rats and compared with untreated and healthy control groups. After 16 days of treatment, CHIT-FSE represented the best performance for controlling the serum levels of the studied biochemical (lipid profile and blood glucose level) and hormonal (insulin, testosterone, luteinizing, and follicle-stimulating hormone) parameters. Considering the negligible therapeutic activity of CHIT-TPP, the enhanced activity of CHIT-FSE compared to only FSE was expounded based on the potent action of chitosan nanoparticles in enhanced stabilization, bioavailability, transport, and permeability of the therapeutically important phytomolecules. As per the results of this investigation, supporting medically important biomolecules over chitosan can enhance their therapeutic effectiveness in controlling PCOS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1049/2024/6693566

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The extent of the effect of ecdysteroids on plasma testosterone levels depends on dose, bioavailability, individual microbiome composition and genetic factors, making it difficult to draw uniform conclusions about the overall effect on plasma testosterone levels.

    “It is known from the literature data that the extent of the effect of ecdysteroids on plasma testosterone levels depends on dose, bioavailability, individual microbiome composition and genetic factors, making it difficult to draw uniform conclusions about the overall effect on plasma testosterone levels [49,50].”

    From Prevention of Diet-Induced Obesity by Phytoecdysteroids 20-Hydroxyecdysone and Calonysterone—Unexpected Modulation of Androgen Balance in Normal and Obese Rats (2026) · cites this paper as [49]

    Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bayrami, A., Sojoudi, M., Rahim Pouran, S., Habibi-Yangjeh, A., & Sojoudi, S.
Affiliations
University of Mohaghegh Ardabili (IR)
Corresponding author
Bayrami, Abolfazl
Venue
IET Nanobiotechnology
Published
2024-01
Volume
2024
Issue
1
Pages
6693566-6693566
ISSN
  • 1751-8741 (ISSN-L)
  • 1751-875X
OpenAlex
W4400737063
Cited by
5
References
71
Citations by year
2026: 3 · 2025: 1 · 2024: 1
FWCI
0.86
Type
journal article
Language
en
Open access
Locations
  • IET Nanobiotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Mohaghegh Ardabili
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
polycystic ovary syndrome, chitosan nanoparticles, flaxseed extract, flax, drug delivery, bioavailability enhancement, lipid profile, blood glucose, reproductive hormones, testosterone, insulin, follicle-stimulating hormone, luteinizing hormone
MeSH terms
Animals, Female, Plant Extracts, Polycystic Ovary Syndrome, Rats, Wistar, Flax, Chitosan, Rats, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review